Critical

Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) flare

Vasculitis · Allergy / Immunology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

An ANCA-associated small-vessel vasculitis in patients with asthma and eosinophilia, presenting acutely with vasculitic organ involvement - mononeuritis multiplex, cardiac, renal, GI or alveolar haemorrhage - alongside a severe asthma/eosinophilia flare.

Red flags

  • Cardiac involvement (myocarditis/heart failure - leading cause of death)
  • Alveolar haemorrhage
  • Rapidly progressive glomerulonephritis
  • Mononeuritis multiplex / severe neuropathy

Assessment

Differential diagnosis

  • Severe asthma exacerbation
  • Hypereosinophilic syndrome
  • Other ANCA vasculitis (GPA, MPA)
  • Eosinophilic pneumonia
  • Parasitic infection

Investigations

  • FBC (marked eosinophilia)
  • ANCA (often positive)
  • U&E and urinalysis (renal involvement)
  • Troponin/ECG/echo (cardiac involvement - a major cause of death)
  • CXR/CT chest; nerve conduction if neuropathy
  • CRP/ESR

Management

  • Assess and support organ function; treat any life-threatening manifestation (alveolar haemorrhage, cardiac, severe asthma)
  • Give high-dose corticosteroids promptly
  • Add further immunosuppression (e.g. cyclophosphamide) for severe organ- or life-threatening disease on specialist advice
  • Manage severe asthma component
  • Involve rheumatology/immunology and relevant organ specialties urgently
  • Monitor for treatment complications

Drugs & doses

High-dose corticosteroids (IV methylprednisolone for severe disease)
Cyclophosphamide (or rituximab) for organ/life-threatening involvement per specialist
Supportive organ therapy
Asthma treatment as needed

Disposition

Admit; ICU for organ-threatening disease; rheumatology/immunology and organ specialty involvement.

Complications & pitfalls

  • Cardiomyopathy / heart failure
  • Renal failure
  • Alveolar haemorrhage
  • Permanent neurological deficit

Exam pearls

  • Cardiac involvement drives mortality - check troponin and cardiac function early
  • Consider it in an asthmatic with new eosinophilia and multi-organ symptoms
  • Leukotriene receptor antagonist use has been associated with unmasking the disease when steroids are reduced

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.